A single mosquito bite can quietly redirect the course of a human life, and for more than four in ten people infected with chikungunya virus, that redirection leads not to recovery but to years of chronic joint pain and potential disability. A scoping review of 35 studies, drawing on research published between 2010 and 2024, has now mapped the overlapping biological mechanisms that explain why some infections refuse to end — revealing a disease that mirrors rheumatoid arthritis in its destructive pathways while remaining distinct in its viral origins. The findings point toward a convergence of
PLOS (Public Library of Science)
· Mar 03, 2026
· health
· 20 min de lectura
High
Verificación: Verificado
Scoping Review Maps Multifactorial Pathogenesis of Chronic Chikungunya Arthritis
Chronic chikungunya arthritis causes significant morbidity and reduced quality of life in patients, with irreversible joint damage often requiring surgical intervention.
◉
Health & Medicine
8412 artículos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% coincidencia
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% coincidencia
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% coincidencia
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% coincidencia
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% coincidencia
Cobertura Relacionada
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Sesgo y Encuadre
⚖
Scientific scoping review presents evidence-based analysis of chikungunya arthritis mechanisms with neutral, methodologically transparent framing appropriate for peer-reviewed medical literature.
Bias Direction
center
Confidence
HIGH
Evidence-based scientific reporting using standardized systematic review methodology (PRISMA guidelines). Neutral presentation of research findings with transparent methodology disclosure and quantified study selection process.
Patient lived experience narratives or qualitative patient perspectives on chronic arthritis impact
Geographic/epidemiological context on disease burden in affected populations
Discussion of treatment efficacy or clinical management implications
Economic or healthcare access dimensions of chronic chikungunya arthritis
Impacto Geopolítico
🌎
Scientific study on chikungunya arthritis pathogenesis has no direct geopolitical implications; it is a public health research article without political, military, or strategic dimensions.
Escalation Risk
low
Confidence
HIGH
Lente Económico
📈
Research identifies chronic chikungunya arthritis mechanisms, suggesting potential market for targeted therapeutics and diagnostic tools in affected regions.
Market Signal
mixed
Confidence
MED
Pharmaceutical/Biotechnology
Medical Devices
Healthcare Services
Public Health
Travel/Tourism
Patients in chikungunya-endemic regions face prolonged disability and healthcare costs. Better understanding of pathogenesis may enable earlier interventions, reducing long-term economic burden on households and healthcare systems.
Governments in endemic areas may increase R&D funding for chikungunya treatments and vaccines. Public health agencies may strengthen mosquito control programs and disease surveillance. Potential for WHO priority disease designation could drive international funding and pharmaceutical development incentives.